priors.science/reviews/copd-pharmacotherapy

COPD Pharmacotherapy

The current evidence on 16 claims, ordered from most established to most contested. Each score is the panel’s evidence certainty — how firmly the literature supports the claim as stated.

16claims tracked
140primary papers reviewed
9 Aug 2026latest evidence review
Weeklyre-scored against new papers
5 Established · 9 Likely · 2 Uncertain · 0 Doubtful  |  four-reviewer panel · PICO Framework
ClaimStandingEvidence certaintyCorpus
Long-acting muscarinic antagonists reduce exacerbationsBronchodilatorsEstablished93%8
Dual bronchodilation improves FEV1BronchodilatorsEstablished92%10
Steroids shorten exacerbation recoveryExacerbationEstablished91%7
Inhaled corticosteroids raise pneumonia riskIcs RiskEstablished91%11
Triple therapy cuts exacerbationsTriple TherapyEstablished87%16
Mepolizumab in eosinophilic chronic obstructive pulmonary diseaseBiologicsLikely83%12
Dupilumab cuts exacerbationsBiologicsEarly evidenceLikely78%11
Azithromycin reduces exacerbationsExacerbationEarly evidenceLikely78%10
Tezepelumab in chronic obstructive pulmonary diseaseEmergingLikely77%3
Long-acting muscarinic antagonist plus beta-agonist vs beta-agonist plus inhaled corticosteroid exacerbationsBronchodilatorsLong-standingLikely76%9
Eosinophils predict inhaled corticosteroid responseIcs RiskLikely76%9
Single-inhaler triple therapy adherenceTriple TherapyEarly evidenceLikely76%14
Roflumilast in severe chronic obstructive pulmonary diseaseExacerbationLikely75%10
Inhaled corticosteroid withdrawal and exacerbationsIcs RiskLikely75%11
Triple therapy mortality benefitTriple TherapyEarly evidenceUncertain66%10
Ensifentrine add-on therapyEmergingUncertain50%8
Track COPD Pharmacotherapy.
These claims are re-scored against new papers every week. Track this topic for the full review, including each claim’s challenge and the papers behind it.
Track this topic →
Standing — what the evidence certainty means
Established≥ 85%Strong, consistent evidence. Unlikely to change.
Likely70–84%Well supported, with some gaps or indirect evidence.
Uncertain50–69%Mixed or limited evidence. Genuinely open.
Doubtful30–49%Little support; the weight of evidence leans against it.
Refuted< 30%The evidence contradicts it — confidently false as stated.
Where the evidence sits in time
Early evidenceMost of this evidence is from the last two years.
Long-standingMost of this evidence is older than the rest of this field.